CP41, a novel curcumin analogue, induces apoptosis in endometrial cancer cells by activating the H3F3A/ proteasome-MAPK signaling pathway and enhancing oxidative stress
Authors:
- 3 January 2024
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 338, 122406
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072863)
- Department of Health of Zhejiang Province (11-CX29)
This publication has 40 references indexed in Scilit:
- Enhanced apoptosis, survivin down-regulation and assisted immunochemotherapy by curcumin loaded amphiphilic mixed micelles for subjugating endometrial cancerNanomedicine: Nanotechnology, Biology and Medicine, 2017
- Turning-ON ProteasomesCell Chemical Biology, 2017
- Hippo pathway mediates resistance to cytotoxic drugsProceedings of the National Academy of Sciences, 2017
- Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial eventsCell Death Discovery, 2015
- Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcuminEuropean Journal of Medicinal Chemistry, 2015
- ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancerOncotarget, 2015
- Anticancer molecules targeting fibroblast growth factor receptorsTrends in Pharmacological Sciences, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- Efflux-Mediated Antifungal Drug ResistanceClinical Microbiology Reviews, 2009
- EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1Cell Cycle, 2008